449 related articles for article (PubMed ID: 19755614)
1. Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus.
Soyfoo MS; Roth J; Vogl T; Pochet R; Decaux G
J Rheumatol; 2009 Oct; 36(10):2190-4. PubMed ID: 19755614
[TBL] [Abstract][Full Text] [Related]
2. Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
Tydén H; Lood C; Gullstrand B; Jönsen A; Nived O; Sturfelt G; Truedsson L; Ivars F; Leanderson T; Bengtsson AA
Rheumatology (Oxford); 2013 Nov; 52(11):2048-55. PubMed ID: 23942785
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis.
Benoit S; Toksoy A; Ahlmann M; Schmidt M; Sunderkötter C; Foell D; Pasparakis M; Roth J; Goebeler M
Br J Dermatol; 2006 Jul; 155(1):62-6. PubMed ID: 16792753
[TBL] [Abstract][Full Text] [Related]
4. Phagocyte-specific S100A8/A9 is upregulated in primary Sjögren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro.
Nicaise C; Weichselbaum L; Schandene L; Gangji V; Dehavay F; Bouchat J; Balau B; Vogl T; Soyfoo MS
Clin Exp Rheumatol; 2017; 35(1):129-136. PubMed ID: 27749214
[TBL] [Abstract][Full Text] [Related]
5. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.
Tydén H; Lood C; Gullstrand B; Jönsen A; Ivars F; Leanderson T; Bengtsson AA
Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135
[TBL] [Abstract][Full Text] [Related]
6. Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina.
Miyamoto S; Ueda M; Ikemoto M; Naruko T; Itoh A; Tamaki S; Nohara R; Terasaki F; Sasayama S; Fujita M
Heart; 2008 Aug; 94(8):1002-7. PubMed ID: 18308864
[TBL] [Abstract][Full Text] [Related]
7. The response of the novel pro-inflammatory molecules S100A8/A9 to exercise.
Mooren FC; Lechtermann A; Fobker M; Brandt B; Sorg C; Völker K; Nacken W
Int J Sports Med; 2006 Sep; 27(9):751-8. PubMed ID: 16944403
[TBL] [Abstract][Full Text] [Related]
8. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
Kim HA; An JM; Nam JY; Jeon JY; Suh CH
J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
[TBL] [Abstract][Full Text] [Related]
9. S100A8, S100A9, and the S100A8/A9 complex in circulating blood are not associated with prostate cancer risk-A re-evaluation study.
Ludwig S; Stephan C; Lein M; Loening SA; Jung K
Prostate; 2007 Sep; 67(12):1301-7. PubMed ID: 17626245
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of cardiac troponin-I in patients with rheumatoid arthritis, systemic lupus erythematosus, primary Sjogren's syndrome and Graves' disease.
Al-Awadhi AM; Olusi S; Hasan EA; Abdullah A
Singapore Med J; 2007 Sep; 48(9):847-9. PubMed ID: 17728967
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
12. Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis.
el-Gamal YM; Heshmat NM; el-Kerdany TH; Fawzy AF
Pediatr Allergy Immunol; 2004 Jun; 15(3):270-7. PubMed ID: 15209962
[TBL] [Abstract][Full Text] [Related]
13. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis.
Frosch M; Ahlmann M; Vogl T; Wittkowski H; Wulffraat N; Foell D; Roth J
Arthritis Rheum; 2009 Mar; 60(3):883-91. PubMed ID: 19248102
[TBL] [Abstract][Full Text] [Related]
14. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
Hermani A; Hess J; De Servi B; Medunjanin S; Grobholz R; Trojan L; Angel P; Mayer D
Clin Cancer Res; 2005 Jul; 11(14):5146-52. PubMed ID: 16033829
[TBL] [Abstract][Full Text] [Related]
15. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin.
Kim HA; Jeon JY; An JM; Koh BR; Suh CH
J Rheumatol; 2012 Apr; 39(4):728-34. PubMed ID: 22337236
[TBL] [Abstract][Full Text] [Related]
18. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
Morgan PE; Sturgess AD; Davies MJ
Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
[TBL] [Abstract][Full Text] [Related]
20. Studies of serum C-reactive protein in systemic lupus erythematosus.
Williams RC; Harmon ME; Burlingame R; Du Clos TW
J Rheumatol; 2005 Mar; 32(3):454-61. PubMed ID: 15742436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]